NCT03271229View on ClinicalTrials.gov

Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Osteo Arthritis Knee
Interventions
BIOLOGICAL

Concentrated Bone Marrow Aspirate (BMAC)

Participants will have a knee injected with BMAC stem cells harvested from the iliac crest

BIOLOGICAL

Platelet-Rich Plasma (PRP)

Participants will have a knee injected with Platelet-Rich Plasma (PRP) obtained from a venous whole blood draw from the antecubital vein.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03271229 - Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter